Found: 112
Select item for more details and to access through your institution.
A Method for Measuring Naringenin in Biological Fluids and Its Disposition from Grapefruit Juice by Man.
- Published in:
- Pharmacology, 1998, v. 56, n. 6, p. 314, doi. 10.1159/000028215
- By:
- Publication type:
- Article
Lipophilic Beta-Blockers Inhibit Rat Skeletal Muscle Mitochondrial Respiration.
- Published in:
- Pharmacology, 1993, v. 47, n. 5, p. 295, doi. 10.1159/000139110
- By:
- Publication type:
- Article
Lack of Effect of Glutathione Depletion by L-Buthionine-S,R-Sulfoximine on Gentamicin Nephrotoxicity in Rats.
- Published in:
- Pharmacology, 1990, v. 40, n. 5, p. 250, doi. 10.1159/000138669
- By:
- Publication type:
- Article
Reversible, Narcotic-Associated Mental Status Impairment in Patients with Metastatic Cancer.
- Published in:
- Pharmacology, 1987, v. 35, n. 1, p. 47, doi. 10.1159/000138294
- By:
- Publication type:
- Article
A plea for prices in physician prescribing.
- Published in:
- 1991
- By:
- Publication type:
- Letter
Clinical Pharmacology.
- Published in:
- JAMA: Journal of the American Medical Association, 1991, v. 265, n. 23, p. 3107, doi. 10.1001/jama.1991.03460230057008
- By:
- Publication type:
- Article
Clinical pharmacology.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Optimizing metoclopramide control of cisplatin-induced emesis.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Are drugs for rare diseases 'essential'?
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
Are drugs for rare diseases "essential"?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Accumulation of Normeperidine, An Active Metabolite of Meperidine, in Patients with Renal Failure or Cancer.
- Published in:
- Annals of Internal Medicine, 1977, v. 86, n. 6, p. 738, doi. 10.7326/0003-4819-86-6-738
- By:
- Publication type:
- Article
Propoxyphene (Dravon®) Addiction and Withdrawal Syndrome.
- Published in:
- Annals of Internal Medicine, 1969, v. 70, n. 4, p. 773, doi. 10.7326/0003-4819-70-4-773
- By:
- Publication type:
- Article
Urinary Clusterin in Chronic Nephrotoxicity in the Rat.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1993, v. 202, n. 4, p. 487, doi. 10.3181/00379727-202-43564
- By:
- Publication type:
- Article
Measurement of Urinary Clusterin as an Index of Nephrotoxicity.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1992, v. 199, n. 1, p. 93, doi. 10.3181/00379727-199-43335
- By:
- Publication type:
- Article
Adaptation to Nephrotoxic Chemicals<sup>1</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1988, v. 189, n. 3, p. 338, doi. 10.3181/00379727-189-42816
- By:
- Publication type:
- Article
In Vitro Response of Hepatic Lysosomes to Endogenous and Exogenous Cationic Compounds.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1984, v. 176, n. 4, p. 346, doi. 10.3181/00379727-176-41881
- By:
- Publication type:
- Article
Comparison of Antiarrhythmic Effects of Procainamide, N-Acetylprocainamide, and p-Hydroxy-N-(3-diethylaminopropyl)benzamide.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1982, v. 169, n. 2, p. 156, doi. 10.3181/00379727-169-41325
- By:
- Publication type:
- Article
Effects of Procainamide and N-Acetylprocainamide on Myocardial Contractility in Ischemic Isolated Rabbit Hearts.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1981, v. 168, n. 3, p. 350, doi. 10.3181/00379727-168-41285
- By:
- Publication type:
- Article
N-Acetylprocainamide: An Active Metabolite of Procainamide<sup>1</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1974, v. 146, n. 2, p. 358, doi. 10.3181/00379727-146-38104
- By:
- Publication type:
- Article
The Procaine Esterase Activity of Serum from Different Mammalian Species<sup>1</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1972, v. 140, n. 3, p. 1059, doi. 10.3181/00379727-140-36611
- By:
- Publication type:
- Article
The Heart Rate Response to Atropine in Uremic Patients, Obese Subjects Before and During Fasting, and Patients with Other Chronic Illnesses<sup>1</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1972, v. 139, n. 2, p. 390, doi. 10.3181/00379727-139-36150
- By:
- Publication type:
- Article
Improving how we evaluate the toxicity of approved drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 1, p. 1, doi. 10.1016/j.clpt.2006.03.006
- By:
- Publication type:
- Article
Informed consent or acknowledgment of disclosure
- Published in:
- 2005
- By:
- Publication type:
- Letter
Interpretation of opioid levels: Comparison of levels during chronic pain therapy to levels from forensic autopsies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 4, p. 324, doi. 10.1016/j.clpt.2004.10.013
- By:
- Publication type:
- Article
Reply.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 1, p. 98, doi. 10.1016/j.clpt.2004.01.019
- By:
- Publication type:
- Article
Treatment of Urinary Incontinence with Anticholinergics in Patients taking Cholinesterase Inhibitors for Dementia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 5, p. 484, doi. 10.1016/j.clpt.2004.01.015
- By:
- Publication type:
- Article
Evolving ways that drug therapy is individualized.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 3, p. 197, doi. 10.1016/S0009-9236(03)00189-9
- By:
- Publication type:
- Article
Rational prescribing of essential medicines.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 2, p. 195, doi. 10.1016/S0009-9236(03)00122-X
- By:
- Publication type:
- Article
What has been the impact of the concept of essential drugs?
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 4, p. 275, doi. 10.1016/S0009-9236(03)00003-1
- By:
- Publication type:
- Article
Drug labeling should be kept current.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 1, p. 4, doi. 10.1067/mcp.2003.20
- By:
- Publication type:
- Article
Who should have access to the research data?
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 5, p. 309, doi. 10.1067/mcp.2002.123943
- By:
- Publication type:
- Article
Thoughts from the Editor.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 1, p. 1, doi. 10.1067/mcp.2002.121968
- By:
- Publication type:
- Article
An open invitation for an explanation about how drug prices are set.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 3, p. 205, doi. 10.1067/mcp.2001.116146
- By:
- Publication type:
- Article
Clinical Pharmacology & Therapeutics Annual report 2000.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 3, p. 299, doi. 10.1067/mcp.2001.118185
- By:
- Publication type:
- Article
Counterfeit and substandard drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 4, p. 189, doi. 10.1067/mcp.2001.114672
- By:
- Publication type:
- Article
Centers for Education and Research in Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 2, p. 109, doi. 10.1067/mcp.2000.108505
- By:
- Publication type:
- Article
Annual Report 1999.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 5, p. 579, doi. 10.1067/mcp.2000.107481
- By:
- Publication type:
- Article
Are we treating health or physical appearance when we prescribe drugs for obesity?
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 3, p. 193, doi. 10.1067/mcp.2000.105242
- By:
- Publication type:
- Article
Clinical pharmacology: The scientific basis of therapeutics<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 66, n. 1, p. 2, doi. 10.1016/S0009-9236(99)70047-0
- By:
- Publication type:
- Article
New headings for the Table of Contents.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 3, p. 235, doi. 10.1016/S0009-9236(99)70101-3
- By:
- Publication type:
- Article
Drugs and the liver.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 353, doi. 10.1016/S0009-9236(98)90064-9
- By:
- Publication type:
- Article
Comment.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 4, p. 465, doi. 10.1016/S0009-9236(98)90078-9
- By:
- Publication type:
- Article
Annual report to the Editorial Advisory Council, 1996.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 62, n. 2, p. 230, doi. 10.1016/S0009-9236(97)90072-2
- By:
- Publication type:
- Article
Decreasing publication bias.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 1, p. 1, doi. 10.1016/S0009-9236(98)90115-1
- By:
- Publication type:
- Article
What should authors expect from the reviewers and the editors of Clinical Pharmacology & Therapeutics?
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 61, n. 4, p. 497, doi. 10.1016/S0009-9236(97)90206-X
- By:
- Publication type:
- Article
Note from the Editor.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 61, n. 4, p. 496, doi. 10.1016/S0009-9236(97)90205-8
- By:
- Publication type:
- Article
Note from the editor.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 60, n. 3, p. 357, doi. 10.1016/S0009-9236(96)90065-X
- By:
- Publication type:
- Article
Publication and proprietary information.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 4, p. 367, doi. 10.1016/S0009-9236(96)90102-2
- By:
- Publication type:
- Article
Essential drugs and the WHO Model List: Addressing new issues<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 3, p. 251, doi. 10.1016/S0009-9236(96)80001-4
- By:
- Publication type:
- Article